Eli Lilly and (LLY)
NYSE: LLY
· Real-Time Price · USD
723.31
-1.23 (-0.17%)
At close: Sep 29, 2025, 1:22 PM
Neuroscience Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 344M | 71.9M | +26.42% |
| Mar 31, 2025 | 272.1M | -196.9M | -41.98% |
| Sep 30, 2024 | 469M | -18M | -3.70% |
| Jun 30, 2024 | 487M | -1.59B | -76.57% |
| Mar 31, 2024 | 2.08B | 331.4M | +18.97% |
| Sep 30, 2023 | 1.75B | 76.1M | +4.55% |
| Jun 30, 2023 | 1.67B | 315M | +23.23% |
| Mar 31, 2023 | 1.36B | -39.7M | -2.84% |
| Sep 30, 2022 | 1.4B | -79.8M | -5.41% |
| Jun 30, 2022 | 1.48B | 21.3M | +1.46% |
| Mar 31, 2022 | 1.45B | -52.2M | -3.47% |
| Sep 30, 2021 | 1.51B | -129M | -7.89% |
| Jun 30, 2021 | 1.64B | 191.6M | +13.27% |
| Mar 31, 2021 | 1.44B | 110.4M | +8.28% |
| Sep 30, 2020 | 1.33B | 64.8M | +5.11% |
| Jun 30, 2020 | 1.27B | 67.1M | +5.58% |
| Mar 31, 2020 | 1.2B | 54.1M | +4.72% |
| Sep 30, 2019 | 1.15B | -49.8M | -4.16% |
| Jun 30, 2019 | 1.2B | 184.5M | +18.22% |
| Mar 31, 2019 | 1.01B | n/a | n/a |
| Dec 31, 2015 | n/a | n/a | n/a |
| Sep 30, 2015 | n/a | n/a | n/a |
| Jun 30, 2015 | n/a | n/a | n/a |
| Mar 31, 2015 | n/a | n/a | n/a |
| Dec 31, 2014 | n/a | n/a | n/a |
| Sep 30, 2014 | n/a | n/a | n/a |
| Jun 30, 2014 | n/a | n/a | n/a |
| Mar 31, 2014 | n/a | n/a | n/a |
| Dec 31, 2013 | n/a | n/a | n/a |
| Sep 30, 2013 | n/a | n/a | n/a |
| Jun 30, 2013 | n/a | n/a | n/a |
| Mar 31, 2013 | n/a | n/a | n/a |
| Dec 31, 2012 | n/a | n/a | n/a |
| Sep 30, 2012 | n/a | n/a | n/a |
| Jun 30, 2012 | n/a | n/a | n/a |
| Mar 31, 2012 | n/a | n/a | n/a |
| Sep 30, 2011 | n/a | n/a | n/a |
| Jun 30, 2011 | n/a | n/a | n/a |
| Mar 31, 2011 | n/a | n/a | n/a |
| Sep 30, 2010 | n/a | n/a | n/a |